SGLT2 Inhibitors Improve Cardiac Failure by Reducing Whole-Body Oxygen Demand: A Hypothesis Takeshi OnoueMasaharu Kataoka Current Opinion 07 November 2022 Pages: 1025 - 1030
The Effect of Nitazoxanide on the Clinical Outcomes in Patients with COVID-19: A Systematic Review and Meta-Analysis of Randomized Controlled Trials Mohamed AbuelazmAhmed GhanemBasel Abdelazeem Systematic Review Open access 31 October 2022 Pages: 1031 - 1047
Efficacy and Safety of Saroglitazar in Patients with Cardiometabolic Diseases: A Systematic Review and Meta-Analysis of Randomized Controlled Trials Devarapalli Ranjani DurgaNadella MounikaRamu Adela Systematic Review 04 November 2022 Pages: 1049 - 1064
COVID-19 mRNA Vaccines: A Retrospective Observational Pharmacovigilance Study Francesco FerraraCarolina MancanielloAntonio Vitiello Original Research Article 23 October 2022 Pages: 1065 - 1074
Cost-Utility Analysis Comparing Direct Oral Anticoagulant and Low Molecular Weight Heparin Therapies for Secondary Prevention of Cancer-Associated Thrombosis Young Eun ShinArun KumarWenchen (Kenneth) Wu Original Research Article 31 October 2022 Pages: 1075 - 1083
Budget Impact Analysis of Idecabtagene Vicleucel for the Treatment of Adult Patients with Relapsed or Refractory Multiple Myeloma in the US Buthainah GhanemLu Shi Original Research Article 01 November 2022 Pages: 1085 - 1092
Pharmacokinetics of Glepaglutide, A Long-Acting Glucagon-Like Peptide-2 Analogue: A Study in Healthy Subjects Mikkel Askjær AgersnapKim SonneMark Berner-Hansen Original Research Article Open access 02 November 2022 Pages: 1093 - 1100
Pharmacokinetics of Morphine Sulfate Orodispersible Tablets and Bioequivalence with Immediate-Release Oral Morphine Sulfate Formulations in Healthy Adult Subjects Under Fasting Conditions: Single-Dose Comparative Bioavailability Studies Nicolas Atrux-TallauZulaikha NaimiEric-Olivier Jaudinot Original Research Article Open access 04 November 2022 Pages: 1101 - 1112
Depicting Risperidone Safety Profiles in Clinical Trials Across Different Diagnoses Using a Dopamine D2-Based Pharmacological Class Effect Query Defined by FAERS Seth C. HopkinsAjay OgiralaKenneth S. Koblan Original Research Article Open access 09 November 2022 Pages: 1113 - 1121